EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology

Aurélien Fouillen, Pierre Couvineau, Bernard Mouillac, Julien Bous

Molecular and Cellular Endocrinology · 2026-10 · 620 · 112835

DOI: 10.1016/j.mce.2026.112835 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular and Cellular Endocrinology, 2026-10. Verfasst von Aurélien Fouillen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Cedex 5, Montpellier, 34094, France. Hauptthemen laut MEDLINE: Receptors, Vasopressin, Small Molecule Libraries. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arginine-vasopressin (AVP) is well known for its antidiuretic effect, which is mediated through activation of the kidney V2 receptor subtype (V2R). Here, we provide a detailed overview of the evolution of our understanding of this system, from the pioneering work of Schafer and Oliver to recent studies that characterize its physiological, pharmacological, and molecular mechanistic features. Recent breakthroughs in cryo-electron microscopy (cryo-EM) have significantly advanced our understanding of how V2R interacts with its cognate ligand. Furthermore, these structural insights help explain how small molecules developed over the past three decades bind to and modulate receptor activity. Together, these advances open new therapeutic perspectives for the treatment of V2R-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, VasopressinSmall Molecule LibrariesHumansAnimalsCryoelectron MicroscopyLigandsArginine VasopressinAntidiuretic Hormone Receptor AntagonistsModels, Molecular

Stichwörter der Autor:innen

AVPCryo-EMGPCRSmall-molecule ligandsTherapeutic strategiesTolvaptanV2R

Substanzen

Receptors, VasopressinLigandsArginine VasopressinAntidiuretic Hormone Receptor AntagonistsSmall Molecule Libraries

Autor:innen und Institutionen

  • Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Cedex 5, Montpellier, 34094, France.
  • Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Cedex 5, Montpellier, 34094, France. Electronic address: bernard.mouillac@igf.cnrs.fr.
  • Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Cedex 5, Montpellier, 34094, France; Karolinska Institutet, Department Physiology & Pharmacology, Sec Receptor Biology & Signaling, Biomedicu…

Förderung

  • French National Research Agency
  • Centre National de la Recherche Scientifique
  • Institut National de la Santé et de la Recherche Médicale
  • Université de Montpellier

Zitieren

APA

Fouillen, A., Couvineau, P., Mouillac, B., & Bous, J. (2026). A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology. Molecular and Cellular Endocrinology, 620, 112835. https://doi.org/10.1016/j.mce.2026.112835

Vancouver

Fouillen A, Couvineau P, Mouillac B, Bous J. A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology. Molecular and Cellular Endocrinology. 2026;620:112835. doi:10.1016/j.mce.2026.112835

BibTeX
@article{Fouillen2026,
  author = {Fouillen, Aurélien and Couvineau, Pierre and Mouillac, Bernard and Bous, Julien},
  title = {A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  volume = {620},
  pages = {112835},
  doi = {10.1016/j.mce.2026.112835}
}
Kostenlos starten →